Browse > Article
http://dx.doi.org/10.3961/jpmph.2010.43.1.9

The Validity and Reliability of a Screening Questionnaire for Parkinson's Disease in a Community  

Kim, Jong-Hun (Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine)
Cheong, Hae-Kwan (Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine)
Lee, Chong-Sik (Department of Neurology, University of Ulsan, College of Medicine, Asan Medical Center)
Yi, Sung-Eun (Department of Nursing, Kwandong University College of Medicine)
Park, Kun-Woo (Department of Neurology, Korea University College of Medicine)
Publication Information
Journal of Preventive Medicine and Public Health / v.43, no.1, 2010 , pp. 9-17 More about this Journal
Abstract
Objectives: Parkinson's disease is one of the most common neurodegenerative diseases in the elderly population. In order to estimate the prevalence of Parkinson's disease in the community, the application of a good screening tool is essential. We evaluated the validity and reliability of a Parkinson's disease screening questionnaire and propose an alternative measure to improve its validity for use in community surveys. Methods: We designed the study in a three-phase approach consisting of a screening questionnaire, neurologic examination, and confirmatory examination. A repeated survey was administered to patients with disease detected in the community and on 150 subjects. We examined internal consistency using Cronbach's alpha test, test-retest reliability using the kappa statistic, and validity using sensitivity, specificity, and ROC curves. Unadjusted odds ratios were utilized for the estimation of weights for each questionnaire item. Results: The Cronbach's alpha of the questionnaire was 0.708. The kappa statistic for test-retest reliability was good to generally fair in most of the items. When newly proposed weighting scores were used, the optimum cut-off value was 7/8. When cut-off value was 5/6 for surveying prevalence in a community, the sensitivity was 0.98, and the specificity was 0.61, with simultaneous improvement in reliability. Conclusions: We recommend 5/6 as the ideal cut-off value for the survey of PD prevalence in community. This questionnaire designed for the Korean community could help future epidemiologic studies of PD.
Keywords
Screening; Questionnaire; Validity; Reliability; Parkinson's disease; Community;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Viera AJ, Garrett JM. Understanding interobserver agreement: The kappa statistic. Fam Med 2005; 37(5): 360-363.
2 Racette BA, Rundle M, Parsian A, Perlmutter JS. Evaluation of a screening questionnaire for genetic studies of Parkinson's disease. Am J Med Genet 1999; 88(5): 539- 543.   DOI   ScienceOn
3 Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999; 52(6): 1214-1220.   DOI   ScienceOn
4 Newman EJ, Grosset KA, Grosset DG. Geographical difference in Parkinson's disease prevalence within West Scotland. Mov Disord 2009; 24(3): 401-406.   DOI   ScienceOn
5 Seo WK, Koh SB, Kim BJ, Yu SW, Park MH, Park KW, et al. Prevalence of Parkinson's disease in Korea. J Clin Neurosci 2007; 14(12): 1155-1157.   DOI   ScienceOn
6 Jhoo JH, Kim KW, Lee DY, Youn JC, Lee TJ, Choo IH, et al. Comparison of the performance in two different Korean versions of mini-mental state examination: MMSE-KC and K-MMSE. J Korean Neuropsychiatr Assoc 2005; 44(1): 98-104. (Korean)
7 Nicoletti A, Salemi G, Morgante L, Le Pira F, Epifanio A, Reggio A, et al. A screening instrument for a Sicilian neuroepidemiological survey in the elderly. Arch Gerontol Geriatr 2004; 38(1): 37-44.   DOI   ScienceOn
8 Chan DK, Hung WT, Wong A, Hu E, Beran RG. Validating a screening questionnaire for parkinsonism in Australia. J Neurol Neurosurg Psychiatry 2000; 69(1): 117-120.   DOI   ScienceOn
9 von Campenhausen S, Bornschein B, Wick R, Bötzel K, Sampaio C, Poewe W, et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005; 15(4): 473-490.   DOI   ScienceOn
10 MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000; 123(Pt 4): 665-676.   DOI
11 Wang SJ, Fuh JL, Liu CY, Lin KP, Chang R, Yih JS, et al. Parkinson's disease in Kin-Hu, Kinmen: A community survey by neurologists. Neuroepidemiology 1994; 13(1-2): 69-74.   DOI   ScienceOn
12 Yip CW, Tan EK. Test-retest repeatability of assessing environmental and lifestyle factors in Parkinson's disease. Mov Disord 2008; 23(7): 1032-1036.   DOI   ScienceOn
13 Taylor CA, Saint-Hilaire MH, Cupples LA, Thomas CA, Burchard AE, Feldman RG, et al. Environmental, medical, and family history risk factors for Parkinson's disease: A New England-based case control study. Am J Med Genet 1999; 88(6): 742-749.   DOI   ScienceOn
14 Rare Disease Center, Korea Centers for Disease Prevention and Control. Genetic and rare disease statistics. [cited 2009 Sep 1]; Available from: URL:http://helpline.cdc.go.kr/web/ download/download_view.html-idx=252& bname= cyber&cate_idx=0000000003. (Korean)
15 Tanner CM, Gilley DW, Goetz CG. A brief screening questionnaire for parkinsonism. Ann Neurol 1990; 28: 267- 268.
16 Duarte J, Claveria LE, de Pedro-Cuesta J, Sempere AP, Coria F, Calne DB. Screening Parkinson's disease: A validated questionnaire of high specificity and sensitivity. Mov Disord 1995; 10(5): 643-649.   DOI   ScienceOn
17 Morgante L, Rocca WA, Di Rosa AE, De Domenico P, Grigoletto F, Meneghini F, et al. Prevalence of Parkinson's disease and other types of parkinsonism: A door-to-door survey in three Sicilian municipalities. The Sicilian Neuro- Epidemiologic Study (SNES) Group. Neurology 1992; 42(10): 1901-1907.   DOI
18 Mutch WJ, Smith WC, Scott RF. A screening and alerting questionnaire for parkinsonism. Neuroepidemiology 1991; 10(3): 150-156.   DOI
19 Yang DW, Cho B, Chey JY, Kim SY, Kim BS. The development and validation of Korean Dementia Screening Questionnaire (KDSQ). J Korean Neurol Assoc 2002; 20(2): 135-141. (Korean)
20 Sarangmath N, Rattihalli R, Ragothaman M, Gopalkrishna G, Doddaballapur S, Louis ED, et al. Validity of a modified Parkinson's disease screening questionnaire in India: Effects of literacy of participants and medical training of screeners and implications for screening efforts in developing countries. Mov Disord 2005; 20(12): 1550- 1556.   DOI   ScienceOn
21 Taylor KS, Counsell CE, Harris CE, Gordon JC. Screening for undiagnosed parkinsonism in people aged 65 years and over in the community. Parkinsonism Related Disord 2006; 12(2): 79-85.   DOI   ScienceOn
22 Racette BA, Tabbal SD, Jennings D, Good LM, Perlmutter JS, Evanoff BA. A rapid method for mass screening for parkinsonism. Neurotoxicology 2006; 27(3): 357-361.   DOI   ScienceOn
23 Park J, Yoo CI, Sim CS, Kim JW, Yi Y, Shin YC, et al. A retrospective cohort study of Parkinson's disease in Korean shipbuilders. Neurotoxicology 2006; 27(3): 445- 449.   DOI   ScienceOn
24 Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33(1): 159-174.   DOI   ScienceOn